NCB Busts Another Illegal Drug Factory In Vapi

Ahmedabad : The Ahmedabad Zonal Unit of the Narcotics Control Bureau on Saturday busted an illegal drug manufacturing facility in Vapi city of Valsad district in Gujarat.

The agency seized 68 kg of raw ingredients used to manufacture Alprazolam and Nordiazepam tablets, which can be processed and sold only on receipt of government license and only in restricted quantities.

The Active Pharmaceutical Ingredients (API) used in the manufacture of the prescription drugs were found in powder form, and sources in the NCB said four persons apprehended in the case were allegedly about to make tablets from the drug and illegally sell it in other states.

While Alprazolam is popularly marketed as Xanax and is used to treat anxiety and panic attacks, Nordazepam is an anticonvulsant, muscle relaxant and has sedative properties. Their misuse as substance abuse is well documented in India and other countries.

Of the four persons apprehended, two are residents of Maharashtra while the other two are from Telangana.
Sources told Mirror that the accused were under surveillance and NCB raided the premises on June 4 where they found incriminating evidence of illegal manufacture of the drugs along with equipment required to do so successfully.

This is the second backyard drug manufacturing unit busted in Gujarat by the NCB. In August 2021, it raided an inter-state drug cartel that was manufacturing Mephedrone, also in Vapi city.

  • Related Posts

    Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

    ‘Where the product in question is a life-saving drug, the Court has to err in favour of public interest’, said the bench The Delhi High Court on Monday cleared the…

    DoP may exempt 11 more drugs from public procurement rules

    New Delhi: The Department of Pharmaceuticals (DoP) has proposed to add 11 more drugs including insulin and monoclonal antibodies to the list of 84 drug formulations it has mentioned in…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

    Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

    DoP may exempt 11 more drugs from public procurement rules

    DoP may exempt 11 more drugs from public procurement rules

    DoP calls for proposals to set up common facilities for medical device clusters

    DoP calls for proposals to set up common facilities for medical device clusters

    TN Information Commission raps petitioner for abusing RTI Act with excessive requests

    TN Information Commission raps petitioner for abusing RTI Act with excessive requests

    Granules India gets USFDA tentative nod for generic ADHD treatment tablets

    Granules India gets USFDA tentative nod for generic ADHD treatment tablets

    Polymatech begins domestic manufacturing of vein finder devices

    Polymatech begins domestic manufacturing of vein finder devices